Christopher Schuster

3.2k total citations
49 papers, 733 citations indexed

About

Christopher Schuster is a scholar working on Immunology, Dermatology and Economics and Econometrics. According to data from OpenAlex, Christopher Schuster has authored 49 papers receiving a total of 733 indexed citations (citations by other indexed papers that have themselves been cited), including 37 papers in Immunology, 17 papers in Dermatology and 10 papers in Economics and Econometrics. Recurrent topics in Christopher Schuster's work include Psoriasis: Treatment and Pathogenesis (23 papers), Dermatology and Skin Diseases (14 papers) and Health Systems, Economic Evaluations, Quality of Life (10 papers). Christopher Schuster is often cited by papers focused on Psoriasis: Treatment and Pathogenesis (23 papers), Dermatology and Skin Diseases (14 papers) and Health Systems, Economic Evaluations, Quality of Life (10 papers). Christopher Schuster collaborates with scholars based in Austria, United States and Germany. Christopher Schuster's co-authors include Adelheid Elbe‐Bürger, Georg Stingl, Wolfgang Bauer, Christian Fiala, Oliver Brandt, Michael Mildner, Gero Kramer, Elisabeth Riedl, Karin Pfisterer and Dirk Strunk and has published in prestigious journals such as The Journal of Experimental Medicine, SHILAP Revista de lepidopterología and Development.

In The Last Decade

Christopher Schuster

49 papers receiving 726 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Christopher Schuster Austria 16 410 221 117 85 74 49 733
Bram van Cranenbroek Netherlands 18 654 1.6× 76 0.3× 155 1.3× 56 0.7× 64 0.9× 39 1.0k
Maike Wittersheim Germany 13 152 0.4× 286 1.3× 199 1.7× 32 0.4× 24 0.3× 24 766
A. Pérez‐Ferriols Spain 15 217 0.5× 406 1.8× 100 0.9× 99 1.2× 29 0.4× 100 709
Esther van Rijssen Netherlands 13 1.0k 2.5× 104 0.5× 154 1.3× 81 1.0× 30 0.4× 20 1.3k
Razieh Soltani‐Arabshahi Iran 13 303 0.7× 261 1.2× 75 0.6× 203 2.4× 9 0.1× 19 679
Soji YAMAZAKI Japan 14 105 0.3× 197 0.9× 112 1.0× 93 1.1× 28 0.4× 69 658
M.P.M. Andriessen Netherlands 13 215 0.5× 245 1.1× 72 0.6× 50 0.6× 16 0.2× 19 638
Zeinab Aryanian Iran 15 102 0.2× 253 1.1× 56 0.5× 97 1.1× 103 1.4× 99 608
Gordana Zamolo Croatia 17 141 0.3× 184 0.8× 158 1.4× 56 0.7× 26 0.4× 66 720
Haruka Miki Japan 14 243 0.6× 49 0.2× 127 1.1× 113 1.3× 9 0.1× 39 522

Countries citing papers authored by Christopher Schuster

Since Specialization
Citations

This map shows the geographic impact of Christopher Schuster's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christopher Schuster with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christopher Schuster more than expected).

Fields of papers citing papers by Christopher Schuster

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christopher Schuster. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christopher Schuster. The network helps show where Christopher Schuster may publish in the future.

Co-authorship network of co-authors of Christopher Schuster

This figure shows the co-authorship network connecting the top 25 collaborators of Christopher Schuster. A scholar is included among the top collaborators of Christopher Schuster based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christopher Schuster. Christopher Schuster is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Riedl, Elisabeth, Andreas Pinter, Antonio Costanzo, et al.. (2024). Baseline Characteristics and mNAPSI Change from Baseline Scores Through Month 12 for Patients with Moderate-to-Severe Plaque Psoriasis and Concomitant Nail Psoriasis Treated with Biologics from PSoHO. Dermatology and Therapy. 14(5). 1327–1335. 3 indexed citations
2.
Reich, Adam, Andreas Pinter, Julia‐Tatjana Maul, et al.. (2023). Speed of clinical improvement in the real‐world setting from patient‐reported Psoriasis Symptoms and Signs Diary: Secondary outcomes from the Psoriasis Study of Health Outcomes through 12 weeks. Journal of the European Academy of Dermatology and Venereology. 37(9). 1825–1840. 6 indexed citations
3.
Pinter, Andreas, Antonio Costanzo, Sanjay Khattri, et al.. (2023). Comparative Effectiveness and Durability of Biologics in Clinical Practice: Month 12 Outcomes from the International, Observational Psoriasis Study of Health Outcomes (PSoHO). Dermatology and Therapy. 14(6). 1479–1493. 8 indexed citations
4.
Kirkham, Bruce, Alexander Egeberg, Frank Behrens, et al.. (2023). A Comprehensive Review of Ixekizumab Efficacy in Nail Psoriasis from Clinical Trials for Moderate-to-Severe Psoriasis and Psoriatic Arthritis. Rheumatology and Therapy. 10(5). 1127–1146. 5 indexed citations
5.
Egeberg, Alexander, Joseph F. Merola, Knut Schäkel, et al.. (2023). Efficacy of ixekizumab in patients with moderate-to-severe plaque psoriasis and prediabetes or type 2 diabetes. Frontiers in Medicine. 9. 1092688–1092688. 2 indexed citations
6.
Piaserico, Stefano, Elisabeth Riedl, Lev Pavlovsky, et al.. (2023). Comparative effectiveness of biologics for patients with moderate-to-severe psoriasis and special area involvement: week 12 results from the observational Psoriasis Study of Health Outcomes (PSoHO). Frontiers in Medicine. 10. 1185523–1185523. 20 indexed citations
7.
Maul, Julia‐Tatjana, Jens Gerwien, Michaela Müller, et al.. (2023). Effectiveness of Biologics, Patient-Reported Outcomes, and Clinical Photography in a Subset of Patients with Moderate-to-Severe Psoriasis: Week 12 Results from the Psoriasis Study of Health Outcomes (PSoHO). Clinical Cosmetic and Investigational Dermatology. Volume 16. 2971–2983. 2 indexed citations
8.
Reich, Kristian, Lars Erik Kristensen, Saxon D. Smith, et al.. (2022). Efficacy and safety of ixekizumab versus adalimumab in patients with active psoriatic arthritis and moderate-to-severe psoriasis: 52-week results from the randomised SPIRIT-H2H trial. Dermatology Practical & Conceptual. 12(2). e2022104–e2022104. 18 indexed citations
9.
Augustin, Matthias, et al.. (2022). The Value of Indirect Comparisons of Systemic Biologics for Psoriasis: Interpretation of Efficacy Findings. Dermatology and Therapy. 12(8). 1711–1727. 2 indexed citations
10.
Sticherling, Michael, Tess McPherson, Raúl de Lucas Laguna, et al.. (2022). Patient Characteristics and Treatment Patterns in European Pediatric Patients with Psoriasis: A Real-World, Cross-Sectional Study. Dermatology and Therapy. 12(8). 1793–1808. 4 indexed citations
11.
Egeberg, Alexander, Lars Erik Kristensen, Ronald Vender, et al.. (2022). Sustained Resolution of Nail Psoriasis Through 5 Years with Ixekizumab: A Post-Hoc analysis from UNCOVER-3. Acta Dermato Venereologica. 102. adv00787–adv00787. 7 indexed citations
12.
Reich, Kristian, Curdin Conrad, Lars Erik Kristensen, et al.. (2021). Network meta-analysis comparing the efficacy of biologic treatments for achieving complete resolution of nail psoriasis. Journal of Dermatological Treatment. 33(3). 1652–1660. 24 indexed citations
13.
Mildner, Michael, Ralf Schmidt, Martin Vierhapper, et al.. (2018). A Preclinical Model for Studying Herpes Simplex Virus Infection. Journal of Investigative Dermatology. 139(3). 673–682. 16 indexed citations
14.
Gschwandtner, Maria, Philip Kienzl, Christopher Schuster, et al.. (2018). The Reticulum-Associated Protein RTN1A Specifically Identifies Human Dendritic Cells. Journal of Investigative Dermatology. 138(6). 1318–1327. 5 indexed citations
15.
Veletzky, Luzia, Christopher Schuster, Stephan W. Aberle, et al.. (2016). Zika virus-induced itching rash in a returning traveller from Brazil. International Journal of Infectious Diseases. 54. 13–14. 3 indexed citations
16.
Jurkin, Jennifer, René Köffel, Christina Fieber, et al.. (2016). Human skin dendritic cell fate is differentially regulated by the monocyte identity factor Kruppel-like factor 4 during steady state and inflammation. Journal of Allergy and Clinical Immunology. 139(6). 1873–1884.e10. 21 indexed citations
17.
Schuster, Christopher, et al.. (2015). Langerhans cell precursors acquire RANK/CD265 in prenatal human skin. Acta Histochemica. 117(4-5). 425–430. 7 indexed citations
18.
Schuster, Christopher, Michael Mildner, Lucian Beer, et al.. (2015). Development of Blood and Lymphatic Endothelial Cells in Embryonic and Fetal Human Skin. American Journal Of Pathology. 185(9). 2563–2574. 8 indexed citations
19.
Schuster, Christopher, Regine Gläser, Christian Fiala, et al.. (2013). Prenatal human skin expresses the antimicrobial peptide RNase 7. Archives of Dermatological Research. 305(6). 545–549. 8 indexed citations
20.
Schuster, Christopher, Christian Fiala, Michael Mildner, et al.. (2012). Phenotypic Characterization of Leukocytes in Prenatal Human Dermis. Journal of Investigative Dermatology. 132(11). 2581–2592. 37 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026